Error loading player: No playable sources found

M102

Robo Meets DoE

Date
April 27, 2020
This product is not available for individual purchase, but it is available as part of the following products:

DoE is a crucial part during the development of potency assays at the Potency Assay Skill Center of Boehringer Ingelheim. The DoE approach is accelerating assay development as it allows the combination of several development experiments in one set. Therefore the total number and extend of assay runs needed is significantly reduced. Furthermore, it increases assay quality as it e.g. helps to identify 2-factor interactions which are only hardly detectable with the OFAT (one factor at the time) approach. Automation of DoEs is done to reduce variability of potency assays which improves the output of the DoEs. The process of DoE automation was split into two parts: Semi-automation of pipetting steps have been introduced in DoE experiments by using automated electronic multichannel pipettes. To further minimize handling time and to improve the assay throughput, fully automation of DoE by using an automation workstation is being established. Opportunities and challenges of the semi and fully automated DoE approaches will be shown.

Speaker

Speaker Image for Karoline Eppler
Boehringer Ingelheim Pharma GmbH & Co. KG

Related Products

Thumbnail for Technical Aspects of Bioassays throughout the Product
Technical Aspects of Bioassays throughout the Product
The technical aspects of bioassay strategies are essential as ever while the biotech industry launches new biologics including modified proteins, DNA, RNA and cell-based therapeutics…
Thumbnail for Bioassays for Bispecifics – Double the Trouble or Double the Fun?
Bioassays for Bispecifics – Double the Trouble or Double the Fun?
The structures and functions of modern biotherapeutics are becoming increasingly complex…
Thumbnail for Bioassays for New Therapies
Bioassays for New Therapies
The number and diversity of biotherapeutic modalities continues to increase. These represent complex modalities such as peptide and peptide conjugates, antisense oligonucleotides, DNA- and RNA-based therapies, drug conjugates, as well as viral vector-based therapeutics…
Thumbnail for Keynote Presentation
Keynote Presentation
Analytics play a critical role in assuring product quality through release testing, process control, deep characterization, defining critical quality attributes, comparability and analytical similarity…